Clinical Care Options in collaboration with the National Eczema Association is hosting an innovative and engaging symposium IL-13 Inhibition in Moderate to Severe Atopic Dermatitis: A Clinical Skills ...

Jason B. Pieper, DVM, MS, DACVD: The causes for otitis externa. I mean, definitely the number one is going to be allergies, which then usually are going to be food allergies and atopic dermatitis or ...

Dupilumab in atopic dermatitis treatment had the most favorable cardiometabolic safety profile when compared with methotrexate and cyclosporine.

The clinical and financial implications of inpatient dermatology were examined, highlighting the need for systemic changes to ...

Many skin conditions appear differently in melanated skin, leading to misdiagnosis and poor treatment. Understanding these ...

The AADA continues to increase awareness among employers of the impact skin conditions have on employee health, productivity, ...

Nemluvio has received approval from the European Commission to treat moderate to severe atopic dermatitis and prurigo ...

The following is a summary of “Impact of COVID-19 disease and vaccination on dermatological immune-mediated inflammatory diseases atopic dermatitis, psoriasis, and vitiligo: a Target2B! substudy,” ...

The medication, also approved in the United States, is the first approved monoclonal antibody that specifically blocks the ...

Opzelura is a treatment for nonsegmental vitiligo in patients 12 and older, making it the first and only cream in the U.S.